Regeneron Pharmaceuticals of Tarrytown, NY, has received US Patent No. 8,255,167, "Non-hypergeometric overlap probability." Methods are provided for determining the probability that the size of an overlap gene set from two different microarrays occurs by chance.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

This webinar will discuss an optimized protocol for methyl-CpG binding domain sequencing (MBD-seq), which enables comprehensive, adequately powered, and cost-effective large-scale methylome-wide association studies (MWAS) of almost all 28 million CpG sites in the genome.